SOBRsafe Inc. (NASDAQ: SOBR) has demonstrated a significant financial and operational upturn in the second quarter of 2025, with a reported 92.3% year-over-year revenue growth to $104,200. This growth is largely fueled by the sales of its innovative SOBRsure(TM) GEN 2 hardware and software, which made up 76.5% of the total revenue. The company also achieved a notable improvement in gross margin by 380 basis points to 57.5%, alongside reducing its net loss to $2.0 million from $2.1 million in the previous year's same quarter.
Operationally, SOBRsafe shipped 178 SOBRsure(TM) GEN 2 devices in Q2 2025, marking a 35.9% increase from the first quarter. The company's annual recurring software subscription revenue saw a 109.6% year-over-year growth, now accounting for 55.2% of the quarterly revenue. Key milestones included the independent third-party validation of the SOBRsure(TM) GEN 2 performance, the introduction of an enhanced B2B e-commerce platform, and the granting of a European Patent for SOBRcheck(TM). Additionally, SOBRsafe has expanded its sales force and ventured into the Family Law market, indicating its strategy to diversify its market presence.
Financially, SOBRsafe reported cash and equivalents of $8.5 million as of June 30, 2025, reflecting its solid financial health and ability to support ongoing growth efforts. The company's transdermal technology, which offers a non-invasive method for alcohol detection, sets it apart in the behavioral health, family law, and consumer sectors. For further details on SOBRsafe's technology and financials, visit https://www.sobrsafe.com.
